Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • Orexigen Therapeutics Inc endocrine news

    Orexigen Therapeutics Inc. (NASDAQ:OREX), La Jolla, Calif. Business: Endocrine Orexigen reduced headcount by 23 (40%) to save cash after a complete response letter from FDA earlier this month for obesity candidate …

    Published on 2/14/2011
  • PDL BioPharma, UCB autoimmune news

    PDL BioPharma Inc. (NASDAQ:PDLI), Incline Village, Nev. UCB Group (Euronext:UCB), Brussels, Belgium Business: Autoimmune The companies settled all legal disputes, including proceedings related to UCB's Cimzia …

    Published on 2/14/2011
  • Silence Therapeutics transplant news

    Silence Therapeutics plc (LSE:SLN), London, U.K. Business: Transplant Silence said it is no longer in discussions to be acquired. The company said it received "a number" of proposals but that none were "compelling to …

    Published on 2/14/2011
  • Abbott pharmaceuticals news

    Abbott Laboratories (NYSE:ABT), Abbott Park, Ill. Business: Pharmaceuticals Abbott will reduce headcount by 1,900 (2%) to about 88,100 to reduce costs. Abbott said the cuts, which will come primarily from U.S. …

    Published on 1/31/2011
  • Arena endocrine news

    Arena Pharmaceuticals Inc. (NASDAQ:ARNA), San Diego, Calif. Business: Endocrine Arena will reduce U.S. headcount by 66 (25%) to about 200 and said FDA requested additional studies for obesity candidate lorcaserin beyond…

    Published on 1/31/2011
  • Aveva Drug Delivery Systems, BioDelivery, MonoSol Rx, Meda drug delivery, neurology news

    Aveva Drug Delivery Systems, Miramar, Fla. BioDelivery Sciences International Inc. (NASDAQ:BDSI), Raleigh, N.C. MonoSol Rx LLC, Warren, N.J. Meda AB (SSE:MEDAA), Solna, Sweden Business: Drug delivery, Neurology MonoSol …

    Published on 1/31/2011
  • Biotec Pharmacon dermatology news

    Biotec Pharmacon ASA (OSE:BIOTEC), Tromso, Norway Business: Dermatology Biotec Pharmacon said that pending board approval it will focus on the development of its SBG as a medical device instead of a therapeutic to treat…

    Published on 1/31/2011
  • China PharmaHub cancer news

    China PharmaHub Corp., Diamond Bar, Calif. Business: Cancer China PharmaHub formed subsidiary CPC NuLife Inc. to commercialize CPC001. China PharmaHub will assist with regulatory applications for the irradiated …

    Published on 1/31/2011
  • Elan drug delivery, neurology, autoimmune news

    Elan Corp. plc (NYSE:ELN), Dublin, Ireland Business: Drug delivery, Neurology, Autoimmune Elan said that earlier this month it reduced headcount by 130 (10%) to about 1,200. Elan said a little less than half of the cuts…

    Published on 1/31/2011
  • Genzyme, NeuroMetrix biopharmaceuticals, neurology news

    Genzyme Corp. (NASDAQ:GENZ), Cambridge, Mass. NeuroMetrix Inc. (NASDAQ:NURO), Waltham, Mass. Business: Biopharmaceuticals, Neurology Genzyme voluntarily re-paid to the Massachusetts Life Sciences Center the $6 million …

    Published on 1/31/2011
  • Molecular Insight diagnostic news

    Molecular Insight Pharmaceuticals Inc. (OTCQB:MIPIQ), Cambridge, Mass. Business: Diagnostic The U.S. Bankruptcy Court for the District of Massachusetts approved Savitr Capital LLC's $45 million investment in Molecular …

    Published on 1/31/2011
  • Orion, Mylan, Novartis neurology news

    Orion Corp. (HSE:ORNAV; HSE:ORNBV), Espoo, Finland Mylan Inc. (NASDAQ:MYL), Canonsburg, Pa. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Neurology Orion filed suit in the U.S. District Court for the …

    Published on 1/31/2011
  • Pfizer pharmaceuticals news

    Pfizer Inc. (NYSE:PFE), New York, N.Y. Business: Pharmaceuticals Pfizer said New York medical centers Rockefeller University, New York University Langone Medical Center, Memorial Sloan-Kettering Cancer Center, The Mount…

    Published on 1/31/2011
  • PharmAthene, Siga infectious news

    PharmAthene Inc. (NYSE-A:PIP), Annapolis, Md. Siga Technologies Inc. (NASDAQ:SIGA), New York, N.Y. Business: Infectious PharmAthene said the Delaware Court of Chancery concluded the trial of PharmAthene's suit claiming …

    Published on 1/31/2011
  • Archimedes Inc. endocrine news

    Archimedes Inc., San Francisco, Calif. Business: Endocrine Healthcare modeling company Archimedes partnered with FDA to model the long-term risks of cardiovascular outcomes in patients receiving obesity drugs. …

    Published on 1/24/2011
  • Cerep admet, supply/service news

    Cerep S.A. (Euronext:ALCER), Celle L'Evescault, France Business: ADMET, Supply/Service Cerep will restructure and reduce headcount by about 41 (20%) to 165 to save cash. The company will close its office in Paris, …

    Published on 1/24/2011
  • DiagnoCure diagnostic news

    DiagnoCure Inc. (TSX:CUR), Quebec City, Quebec Business: Diagnostic DiagnoCure adopted a shareholder rights plan to protect shareholders in the event of a takeover bid. Under the plan, each current and subsequently …

    Published on 1/24/2011
  • Emerging Healthcare Solutions Inc. hepatic, gene/cell therapy news

    Emerging Healthcare Solutions Inc. (Pink:EHSI), Houston, Texas Business: Hepatic, Gene/Cell therapy Emerging Healthcare Solutions and its Celulas Genetica wholly owned subsidiary will form a JV to develop and …

    Published on 1/24/2011
  • Genzyme metabolic news

    Genzyme Corp. (NASDAQ:GENZ), Cambridge, Mass. Business: Metabolic Two Fabry's disease patients sent a Citizen's Petition to FDA seeking to prevent overseas shipments of Genzyme's Fabrazyme agalsidase alfa until all U.S.…

    Published on 1/24/2011
  • GlaxoSmithKline endocrine news

    GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Endocrine GlaxoSmithKline expects to record a legal charge of 2.2 billion ($3.5 billion) in 4Q10 related to additional provisioning for the investigation …

    Published on 1/24/2011
  • Invida, Orexo neurology news

    Invida Group Pte. Ltd., Singapore Orexo AB (SSE:ORX), Uppsala, Sweden Business: Neurology Invida received exclusive marketing rights to Orexo's Abstral fentanyl in Australia, India, Philippines, South Korea, Singapore, …

    Published on 1/24/2011
  • Laboratoires Expanscience S.A., MediGene infectious news

    Laboratoires Expanscience S.A., Paris, France MediGene AG (Xetra:MDG), Martinsried, Germany Business: Infectious MediGene granted Laboratoires Expanscience exclusive marketing rights in France to Veregen sinecatechins. …

    Published on 1/24/2011
  • Advanced Life infectious news

    Advanced Life Sciences Holdings Inc. (OTCBB:ADLS), Woodridge, Ill. Business: Infectious Advanced Life will explore strategic alternatives, including an acquisition or partnership. The decision was based on the company's…

    Published on 1/10/2011
  • Alnylam metabolic, hematology news

    Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), Cambridge, Mass. Business: Metabolic, Hematology Alnylam launched its "Alnylam 5x15" strategy with the goal of moving five RNAi therapeutic programs into advanced clinical …

    Published on 1/10/2011
  • Biohit diagnostic news

    Biohit Oyj (HSE:BIOBV), Helsinki, Finland Business: Diagnostic Biohit said it has decided to hold its plans to spin off its diagnostics business until further notice. The company said that its liquid handling sales and …

    Published on 1/10/2011

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993